Cytokinetics | CYTK - Cash And Equivalent



Cytokinetics reported $74.94M in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
Acadia Pharmaceuticals USD 762M 80.42M Jun/2025
Amgen USD 8.03B 782M Jun/2025
Bayer EUR 4.56B 542M Jun/2025
Biogen USD 2.76B 160.5M Jun/2025
Bristol-Myers Squibb USD 12.6B 1.72B Jun/2025
Cytokinetics USD 74.94M 863.28M Jun/2025
Eisai JPY 285.38B 19.82B Jun/2025
Eli Lilly USD 3.38B 282.6M Jun/2025
Exelixis USD 164.43M 19.32M Jun/2025
Geron USD 79.6M 6.01M Jun/2025
Halozyme Therapeutics USD 61.86M 114.47M Jun/2025
Ionis Pharmaceuticals USD 297.3M 33.11M Jun/2025
Ligand Pharmaceuticals USD 67.67M 189.22M Jun/2025
Merck USD 8.01B 622M Jun/2025
Novartis USD 6.66B 410M Jun/2025
Pfizer USD 1.64B 208M Jun/2025
Regeneron Pharmaceuticals USD 2B 1.09B Jun/2025
Roche Holding CHF 6.98B 2.15B Dec/2024
Sanofi 15.36B 7.37B Jun/2025